Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 29, 2007 11:07 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma: Early Stage Alzheimer's Disease Diagnostic Patent Issued in Australia

LAS VEGAS, May 29, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has received a notice that the Australian patent application...
May 22, 2007 09:37 ET | Source: Samaritan Pharmaceuticals, Inc.

Shire Human Genetic Therapies AB Signs Exclusive Marketing and Distribution Deal With Samaritan to Launch REPLAGAL for Fabry Disease in Greece and Cyprus

LAS VEGAS, May 22, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce it has signed a second exclusive marketing and...
May 15, 2007 09:51 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Breast Cancer Diagnostic Issued U.S. Patent

Unique Advantages: Faster Prognosis With Breast Cancer Diagnosis Taking 1-7 Days Compared to the Traditional 3-Weeks Determines Breast Cancer Tumor Aggressiveness and Likelihood of Cancer ...
May 03, 2007 09:53 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimer's Drug

LAS VEGAS, May 3, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce positive results were attained with its late-stage...
May 01, 2007 09:35 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan to Highlight Its Novel Alzheimer's Drug Caprospinol (SP-233) At BIO International Convention 2007

LAS VEGAS, May 1, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today, it will present its late-stage preclinical drug candidates at...
April 10, 2007 09:28 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Announces the Granting of European Patent for New Type of Cardiovascular Plaque Clearing Drug SP-1000

LAS VEGAS, April 10, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has received a notice that a European Patent has been...
April 05, 2007 06:41 ET | Source: Samaritan Pharmaceuticals, Inc.

AMEX Panel Grants Samaritan Continued AMEX Listing Pursuant to May 31st Extension to Allow for 10Q Filing Demonstrating It Has Regained Compliance

LAS VEGAS, April 5, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) announced today that on April 3, 2007, the American Stock Exchange ("AMEX") notified Samaritan Pharmaceuticals,...
March 28, 2007 11:53 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma Partners PII HIV Drug to Pharmaplaz; Upfront Payment $10 Million

LAS VEGAS, March 28, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, and Pharmaplaz, Ltd., a private Irish healthcare company, announced today...
March 26, 2007 09:55 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Pharma's SP-233 Featured in Zillion Business Review Article

LAS VEGAS, March 26, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today it was featured in the eighteenth edition 2007 of Zillion...
March 08, 2007 09:46 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan's In-Licensed AMPHOCIL Awarded 94 Percent Price Increase With Pricing Approval in Greece

Sales Launch in Greece Expected Next Month AMPHOCIL is the First of Nine Revenue Producing Products In-Licensed to Samaritan LAS VEGAS, March 8, 2007 (PRIME NEWSWIRE) -- Samaritan...